GO
Loading...

Pfizer Inc

More

  • Pfizer to offer contraceptive for developing world Friday, 14 Nov 2014 | 4:54 AM ET

    A major collaboration between Pfizer and several global aid groups is aiming to provide financing to make a new version of an injectable contraceptive, the NYT reports.

  • Final Glance: Pharmaceuticals companies Thursday, 13 Nov 2014 | 6:05 PM ET

    Baxter International Inc. rose$. 75 or 1.1 percent, to $72.08. Bristol-Myers Squibb Co. fell$. 81 or 1.4 percent, to $57.80. Johnson& Johnson rose$. 32 or. 3 percent, to $109.07.

  • Nov 13- Puma Biotechnology Inc said its cancer drug failed as a primary treatment for breast cancer patients in a mid-stage study, sending its shares down 14 percent in extended trading. Puma Biotech's founder and Chief Executive Alan Auerbach had also founded cancer drug developer Cougar Biotech which was sold to Johnson& Johnson for about 1 billion in 2009..

  • Midday Glance: Pharmaceuticals companies Thursday, 13 Nov 2014 | 1:28 PM ET

    Baxter International Inc. rose$. 69 or 1.0 percent, to $72.02. Bristol-Myers Squibb Co. fell$. 77 or 1.3 percent, to $57.84. Hospira fell$. 25 or. 4 percent, to $57.85.

  • Early Glance: Pharmaceuticals companies Thursday, 13 Nov 2014 | 12:16 PM ET

    Baxter International Inc. rose$. 62 or. 9 percent, to $71.95. Bristol-Myers Squibb Co. fell$. 67 or 1.1 percent, to $57.94. Hospira rose$. 06 or. 1 percent, to $58.15.

  • But a series of failed deals, including the collapse of a $55 billion tie-up between UK drugmaker Shire and U.S. peer AbbVie, has led to losses for some of the world's biggest proponents of the strategy, with investors pulling out $3.3 billion in the last two months alone. "The AbbVie/ Shire break, in particular, has led to a far reaching de-risking exercise for many...

  • LONDON, Nov 13- AstraZeneca is developing an antibody treatment to reverse the blood-thinning effect of its heart drug Brilinta in rare emergency situations, such as urgent surgery or in the event of major bleeding. AstraZeneca said on Thursday the experimental antibody product, MEDI2452, was in pre-clinical tests at its MedImmune biotech unit.

  • Final Glance: Pharmaceuticals companies Wednesday, 12 Nov 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 57 or. 8 percent, to $71.33. Bristol-Myers Squibb Co. fell$. 11 or. 2 percent, to $58.61. Hospira rose$. 78 or 1.4 percent, to $58.09.

  • WASHINGTON, Nov 12 Reuters)- U.S. businesses and industry groups urged Congress on Wednesday to give the White House authority to fast-track trade deals before the end of the year, saying it was a critical tool to complete major trade deals. It was signed by companies including Apple Inc, Boeing Co, Exxon Mobil Corp, FedEx Corp, General Electric Co, Pfizer Inc and...

  • NEW YORK, Nov 12- Mathew Martoma, a former portfolio manager at billionaire Steven A. Cohen's SAC Capital Advisors LP hedge fund, on Wednesday lost a bid to stay out of prison while he appeals his insider trading conviction. The 2nd U.S. Circuit Court of Appeals in New York lifted a stay that had enabled Martoma to avoid beginning a nine-year prison sentence for...

  • Most active New York Stock Exchange-traded stocks Wednesday, 12 Nov 2014 | 1:23 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. Bank of America Corp. fell. 2 percent to $17.29 with 47,222,100 shares traded. Ford Motor Co. rose 1.5 percent to $14.58 with 35,749,300 shares traded.

  • Midday Glance: Pharmaceuticals companies Wednesday, 12 Nov 2014 | 1:23 PM ET

    Baxter International Inc. rose$. 24 or. 3 percent, to $71.00. Bristol-Myers Squibb Co. fell$. 05 or. 1 percent, to $58.67. Johnson& Johnson fell$. 05 or percent, to $108.86.

  • Early Glance: Pharmaceuticals companies Wednesday, 12 Nov 2014 | 11:05 AM ET

    Baxter International Inc. rose$. 09 or. 1 percent, to $70.85. Bristol-Myers Squibb Co. rose$. 05 or. 1 percent, to $58.77. Pfizer rose$. 17 or. 6 percent, to $30.49.

  • Final Glance: Pharmaceuticals companies Tuesday, 11 Nov 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 13 or. 2 percent, to $70.76. Bristol-Myers Squibb Co. fell$. 09 or. 2 percent, to $58.72. Hospira rose $1.33 or 2.4 percent, to $57.31.

  • Zoetis shares jump on investment by activist Tuesday, 11 Nov 2014 | 4:44 PM ET

    Zoetis Inc. shares jumped Tuesday on a report that activist investor William Ackman has taken a stake in the animal health company and could push for its sale. The company said that it did receive a call from Ackman indicating that the firm has made an investment in Zoetis. But Zoetis declined to comment on details of that conversation.

  • Midday Glance: Pharmaceuticals companies Tuesday, 11 Nov 2014 | 1:52 PM ET

    Baxter International Inc. rose$. 16 or. 2 percent, to $70.79. Bristol-Myers Squibb Co. fell$. 00 or percent, to $58.81. Hospira rose$. 74 or 1.3 percent, to $56.72.

  • Early Glance: Pharmaceuticals companies Tuesday, 11 Nov 2014 | 10:33 AM ET

    Bristol-Myers Squibb Co. fell$. 04 or. 1 percent, to $58.77. Hospira fell$. 04 or. 1 percent, to $55.94. Johnson& Johnson fell$. 04 or percent, to $108.78.

  • Midday Glance: Pharmaceuticals companies Monday, 10 Nov 2014 | 1:28 PM ET

    Baxter International Inc. fell$. 06 or. 1 percent, to $70.55. Bristol-Myers Squibb Co. rose$. 22 or. 4 percent, to $58.54. Hospira fell$. 33 or. 6 percent, to $55.99.

  • Most active New York Stock Exchange-traded stocks Monday, 10 Nov 2014 | 1:28 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:. AT&T Inc. rose. 5 percent to $35.09 with 10,174,200 shares traded. Alpha Natural Resources Inc. fell 6.6 percent to $2.72 with 10,840,600 shares traded.

  • Early Glance: Pharmaceuticals companies Monday, 10 Nov 2014 | 10:28 AM ET

    Baxter International Inc. fell$. 09 or. 1 percent, to $70.52. Bristol-Myers Squibb Co. fell$. 42 or. 7 percent, to $57.90. Hospira fell$. 16 or. 3 percent, to $56.16.